Prostate Cancer
Combination Therapy Inhibits Angiogenesis and Cell Proliferation In Tumors
Published in Cancer Weekly, May 8th, 2001
While differentiation-inducing agents such as these have demonstrated minimal cancer inhibition when used as monotherapies in clinical experiments, a combination of these agents has resulted in marked effects in cultured cancer cells and in engrafted animals, Johns Hopkins researchers state.
"Our study evaluated the combination of phenylbutyrate (PE) and 13-cis retinoic acid (CRA) as a differentiation and anti-angiogenesis strategy for prostate cancer," R. Pili et al. said in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2001-05-08)
More Articles from Cancer Weekly
- Cancer Pain
Individualized Program Can Help Patients Talk To Their Doctor, Set Pain-Control Goals - Bladder Cancer
Step-By-Step Approach May Reduce Need For Surgery In Patients With Advanced Disease - Brain Cancer
Antisense Treatment Promising for Deadly Tumors - Colon Cancer
Antisense Amyloid Beta Protein Precursor Suppresses Tumor Growth - Melanoma
Interferon Therapy Does Not Inhibit GMK Vaccine Effectiveness - Prostate Cancer
Neoplasia Is More Common In Black Men And May Result In Increased PSA - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
